511 related articles for article (PubMed ID: 24700501)
1. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
[TBL] [Abstract][Full Text] [Related]
2. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434
[TBL] [Abstract][Full Text] [Related]
3. Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line.
Liu R; Li X; Qiang X; Luo L; Hylemon PB; Jiang Z; Zhang L; Zhou H
J Biol Chem; 2015 Dec; 290(52):30988-1002. PubMed ID: 26518876
[TBL] [Abstract][Full Text] [Related]
4. Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Cholestasis.
Sarkar J; Aoki H; Wu R; Aoki M; Hylemon P; Zhou H; Takabe K
Ann Surg Oncol; 2023 Mar; 30(3):1630-1641. PubMed ID: 36396870
[TBL] [Abstract][Full Text] [Related]
5. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.
Studer E; Zhou X; Zhao R; Wang Y; Takabe K; Nagahashi M; Pandak WM; Dent P; Spiegel S; Shi R; Xu W; Liu X; Bohdan P; Zhang L; Zhou H; Hylemon PB
Hepatology; 2012 Jan; 55(1):267-76. PubMed ID: 21932398
[TBL] [Abstract][Full Text] [Related]
6. Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation.
Liu R; Li X; Hylemon PB; Zhou H
Am J Pathol; 2018 Sep; 188(9):2042-2058. PubMed ID: 29963993
[TBL] [Abstract][Full Text] [Related]
7. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients.
Kim H; Kim HJ; Park YT; Kim JS
J Gastrointestin Liver Dis; 2023 Sep; 32(3):371-376. PubMed ID: 37774230
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.
Tan XY; Chang S; Liu W; Tang HH
Gut Liver; 2014 Mar; 8(2):196-204. PubMed ID: 24672662
[TBL] [Abstract][Full Text] [Related]
10. Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.
Indramanee S; Sawanyawisuth K; Silsirivanit A; Dana P; Phoomak C; Kariya R; Klinhom-On N; Sorin S; Wongkham C; Okada S; Wongkham S
Sci Rep; 2019 Nov; 9(1):17266. PubMed ID: 31754244
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
13. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
[TBL] [Abstract][Full Text] [Related]
14. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.
Gentilini A; Lori G; Caligiuri A; Raggi C; Di Maira G; Pastore M; Piombanti B; Lottini T; Arcangeli A; Madiai S; Navari N; Banales JM; Di Matteo S; Alvaro D; Duwe L; Andersen JB; Tubita A; Tusa I; Di Tommaso L; Campani C; Rovida E; Marra F
Hepatology; 2021 Oct; 74(4):2007-2020. PubMed ID: 33959996
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma development: the resurgence of bile acids.
Maroni L; Alpini G; Marzioni M
Hepatology; 2014 Sep; 60(3):795-7. PubMed ID: 24828905
[No Abstract] [Full Text] [Related]
17. Bile acids are nutrient signaling hormones.
Zhou H; Hylemon PB
Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Menakongka A; Suthiphongchai T
World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
[TBL] [Abstract][Full Text] [Related]
19. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.
Dokduang H; Juntana S; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3519-28. PubMed ID: 23812726
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobic bile acid apoptosis is regulated by sphingosine-1-phosphate receptor 2 in rat hepatocytes and human hepatocellular carcinoma cells.
Webster CR; Anwer MS
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G865-73. PubMed ID: 26999807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
